Nat Med. 2001 Sep;7(9):987-9.

Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy.

Source

Steele Laboratory, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School Boston, Massachusetts, USA. jain@steele.mgh.harvard.edu

Comment in

Recognition of tumor blood vessel normalization as a new antiangiogenic concept. [Nat Med. 2004]
Recognition of tumor blood vessel normalization as a new antiangiogenic concept.Hellmann K. Nat Med. 2004 Apr; 10(4):329; author reply 329-30.

PMID:: 11533692; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms

Publication Types

Review

MeSH Terms

LinkOut - more resources

Full Text Sources

Other Literature Sources

COS Scholar Universe

Medical

Supplemental Content

Save items

Related citations in PubMed

Review Tumour vascularisation: a druggable target. [Curr Opin Pharmacol. 2009]
Review Tumour vascularisation: a druggable target.
Bishop-Bailey D. Curr Opin Pharmacol. 2009 Apr; 9(2):96-101. Epub 2008 Dec 4.
Review The quest for surrogate markers of angiogenesis: a paradigm for translational research in tumor angiogenesis and anti-angiogenesis trials. [Curr Mol Med. 2003]
Review The quest for surrogate markers of angiogenesis: a paradigm for translational research in tumor angiogenesis and anti-angiogenesis trials.
Rüegg C, Meuwly JY, Driscoll R, Werffeli P, Zaman K, Stupp R. Curr Mol Med. 2003 Dec; 3(8):673-91.
Modulation of the "blood-tumor" barrier improves immunotherapy. [Cell Cycle. 2008]
Modulation of the "blood-tumor" barrier improves immunotherapy.
Manzur M, Hamzah J, Ganss R. Cell Cycle. 2008 Aug 15; 7(16):2452-5. Epub 2008 Aug 17.
Review Role of angiogenesis in tumor growth and metastasis. [Semin Oncol. 2002]
Review Role of angiogenesis in tumor growth and metastasis.
Folkman J. Semin Oncol. 2002 Dec; 29(6 Suppl 16):15-8.
Review Lessons from multidisciplinary translational trials on anti-angiogenic therapy of cancer. [Nat Rev Cancer. 2008]
Review Lessons from multidisciplinary translational trials on anti-angiogenic therapy of cancer.
Jain RK. Nat Rev Cancer. 2008 Apr; 8(4):309-16.

See reviews... See all...

Cited by over 100 PubMed Central articles

Treatment of colorectal cancer using a combination of liposomal irinotecan (Irinophore C™) and 5-fluorouracil. [PLoS One. 2013]
Treatment of colorectal cancer using a combination of liposomal irinotecan (Irinophore C™) and 5-fluorouracil.
Hare JI, Neijzen RW, Anantha M, Dos Santos N, Harasym N, Webb MS, Allen TM, Bally MB, Waterhouse DN. PLoS One. 2013; 8(4):e62349. Epub 2013 Apr 23.
Vitexicarpin acts as a novel angiogenesis inhibitor and its target network. [Evid Based Complement Alternat...]
Vitexicarpin acts as a novel angiogenesis inhibitor and its target network.
Zhang B, Liu L, Zhao S, Wang X, Liu L, Li S. Evid Based Complement Alternat Med. 2013; 2013:278405. Epub 2013 Feb 12.
A computational model for predicting nanoparticle accumulation in tumor vasculature. [PLoS One. 2013]
A computational model for predicting nanoparticle accumulation in tumor vasculature.
Frieboes HB, Wu M, Lowengrub J, Decuzzi P, Cristini V. PLoS One. 2013; 8(2):e56876. Epub 2013 Feb 28.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for c...
Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy.
Nat Med. 2001 Sep ;7(9):987-9.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: